"Medication Adherence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Voluntary cooperation of the patient in taking drugs or medicine as prescribed. This includes timing, dosage, and frequency.
Descriptor ID |
D055118
|
MeSH Number(s) |
F01.100.150.750.500.600.500 F01.145.488.887.500.600.500 N05.300.150.800.500.600.500
|
Concept/Terms |
Medication Nonadherence- Medication Nonadherence
- Nonadherence, Medication
- Medication Noncompliance
- Noncompliance, Medication
- Medication Non-Adherence
- Medication Non Adherence
- Non-Adherence, Medication
Medication Compliance- Medication Compliance
- Compliance, Medication
- Medication Non-Compliance
- Medication Non Compliance
- Non-Compliance, Medication
|
Below are MeSH descriptors whose meaning is more general than "Medication Adherence".
Below are MeSH descriptors whose meaning is more specific than "Medication Adherence".
This graph shows the total number of publications written about "Medication Adherence" by people in this website by year, and whether "Medication Adherence" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Medication Adherence" by people in Profiles.
-
Wells KJ, Pan TM, Vázquez-Otero C, Ung D, Ustjanauskas AE, Muñoz D, Laronga C, Roetzheim RG, Goldenstein M, Carrizosa C, Nuhaily S, Johnson K, Norton M, Sims E, Quinn GP. Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study. Support Care Cancer. 2016 10; 24(10):4123-30.
-
Sacco WP, Malone JI, Morrison AD, Friedman A, Wells K. Effect of a brief, regular telephone intervention by paraprofessionals for type 2 diabetes. J Behav Med. 2009 Aug; 32(4):349-59.